Principal Investigator
Jaime Merchan
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230988
Clinical Trial Summary
A Phase 1, Multicenter, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of DCSZ11 as a Monotherapy and in Combination in Patients with Advanced or Metastatic Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Colorectal Cancer
Contact Information
Phone Number
305-243-2647